28 results
S-8
EX-5.1
RNXT
RenovoRx Inc
12 Apr 24
Registration of securities for employees
5:14pm
with respect to any part of the Registration Statement within the meaning of the term “expert” as used in Section 11 of the Securities Act or the rules
8-K
EX-10.1
RNXT
RenovoRx Inc
14 Mar 24
Departure of Directors or Certain Officers
4:53pm
Phase 2/3 bile duct cancer trial and other upcoming trials
Manage multi-center oncology trials:
Become a subject matter expert on RenovoRx clinical
8-K
EX-3.1
RNXT
RenovoRx Inc
8 Sep 23
Amendments to Articles of Incorporation or Bylaws
7:41pm
the member reasonably believes are within such other person’s professional or expert competence and who has been selected with reasonable care
8-K
EX-99.1
4aa4ga 4utuxfsde11
17 Aug 23
RenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlights
8:30am
8-K
EX-99.1
83wka9u76bxw
15 May 23
RenovoRx Reports First Quarter 2023 Financial Results and Operational Highlights
8:30am
DEF 14A
wds6dymq
29 Apr 22
Definitive proxy
4:06pm
10-K
h7l7 uo5h2
30 Mar 22
Annual report
7:21am
10-K
EX-3.2
v6xz0byb2yq96i9hg
30 Mar 22
Annual report
7:21am
8-K
EX-3.2
fg2tv7o
31 Aug 21
Amendments to Articles of Incorporation or Bylaws
5:14pm
424B4
9gl 4ylk4nojqr
27 Aug 21
Prospectus supplement with pricing info
6:06am
S-1/A
91jg9ku pqk
5 Aug 21
IPO registration (amended)
5:29pm
S-1/A
EX-10.7
m4kzrw
5 Aug 21
IPO registration (amended)
5:29pm